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Introduction {#febs14336-sec-0001}
============

Mitochondrial homeostasis underpins cell survival. These multifunctional organelles are not only at the heart of cellular energy metabolism but also play key roles in many other processes, including calcium storage, iron metabolism and apoptosis. Maintaining a healthy mitochondrial population presents a huge cellular challenge and, as the primary sources of potentially hazardous reactive oxygen species and instigators of programmed cell death, failure to do so could have disastrous repercussions. This is especially important for the viability of long‐lived, postmitotic cells such as neurons and cardiomyocytes, where the preservation of mitochondria may underpin a healthy human lifespan. The accumulation of dysfunctional mitochondria has been tied to ageing and the progression of many human diseases, ranging from cancer to neurodegeneration. While cell signalling systems such as chaperones and proteases act to survey mitochondrial integrity, mitochondrial quality control also extends to the lysosome‐dependent autophagic turnover of entire organelles. During the selective destruction of damaged mitochondria, termed mitophagy, a portion of the mitochondrial network is gradually engulfed within a double‐membraned autophagosome, known as a mitophagosome. This eventually fuses with a compartment of the endolysosomal system, resulting in the proteolytic degradation of its mitochondrial cargo (Fig. [1](#febs14336-fig-0001){ref-type="fig"}). Notably, mitophagy is not the only lysosomal pathway implicated in mitochondrial turnover; for example, mitochondrial‐derived vesicles (MDVs) can also deliver damaged mitochondrial components to the lysosome and are thus also implicated in quality control [1](#febs14336-bib-0001){ref-type="ref"}. In this review, we will first discuss insights from cell‐based studies that have provoked great interest in the significance of mitophagy as a protective pathway during health and disease. We then describe our current mechanistic understanding of how it is coordinated. Finally, we discuss the advent of new *in vivo* mitophagy models that reveal the striking instances of mitophagy that occur under steady‐state physiological conditions.

![The requirements for mitophagy. Cartoon depicting the molecular events occurring during mitophagy. (1) Fission of the mitochondrial network into individual mitochondrion/mitochondrial fragments; (2) Marking of these to prime them for recognition by the autophagy machinery; (3) Formation of the autophagic phagophore to engulf the primed mitochondrion. Once engulfed, the mitochondrion‐containing autophagosome (mitophagosome) fuses with a lysosome to form the mitolysosomes where degradation and recycling occurs.](FEBS-285-1185-g001){#febs14336-fig-0001}

Reasons to trigger mitophagy {#febs14336-sec-0002}
============================

Multiple mitophagy pathways operate within the cell and fulfil various roles. Mitophagy is thought to perform a housekeeping role under steady‐state conditions, being responsible for the timely turnover of aged organelles. In addition, to combat the potential risks associated with dysfunctional mitochondria, mitophagy can also be rapidly enhanced as a protective mechanism to selectively remove damaged mitochondria and this has been extensively reviewed [2](#febs14336-bib-0002){ref-type="ref"}, [3](#febs14336-bib-0003){ref-type="ref"}, [4](#febs14336-bib-0004){ref-type="ref"}. More recently, it has become apparent that commitment of mitochondria to mitophagy‐dependent degradation is a core mechanism by which organelle quantity and/or functional characteristics may be adjusted. This is a variant of mitophagy, referred to as programmed mitophagy [5](#febs14336-bib-0005){ref-type="ref"}, described to occur independently of mitochondrial damage and is engaged in an array of developmental and physiological contexts.

Important insights into programmed mitophagy were first recorded by the Ney laboratory while studying erythrocyte differentiation and maturation. Erythrocytes rapidly develop from immature erythroblasts generated in the bone marrow over a period of 48--72 h [6](#febs14336-bib-0006){ref-type="ref"}. Erythroblasts are enucleated to form erythrocytes, before all remaining internal organelles and ribosomes are destroyed [6](#febs14336-bib-0006){ref-type="ref"}. During this process, the specific removal of mitochondria occurs via mitophagy [7](#febs14336-bib-0007){ref-type="ref"}, [8](#febs14336-bib-0008){ref-type="ref"}.

In addition to the role of mitophagy in erythrocyte development, mitophagy is also critical for the programmed of elimination of sperm‐contributed paternal mitochondria from fertilised oocytes during embryogenesis in *Caenorhabditis elegans* [9](#febs14336-bib-0009){ref-type="ref"}, [10](#febs14336-bib-0010){ref-type="ref"}, [11](#febs14336-bib-0011){ref-type="ref"}. However, it is not clear as to whether this is also true in mammals [12](#febs14336-bib-0012){ref-type="ref"}, [13](#febs14336-bib-0013){ref-type="ref"}, [14](#febs14336-bib-0014){ref-type="ref"}. Similarly, mitophagy is required for developmentally induced enterocyte cell death which occurs in the midgut of *Drosophila melanogaster* during metamorphosis [15](#febs14336-bib-0015){ref-type="ref"}.

Metabolic reprogramming is a characteristic of many differentiation pathways, and mitophagy has recently been described to influence this process. Programmed mitophagy has been shown to direct the metabolic transition which occurs during cardiomyocyte maturation. During the neonatal period, cardiomyocyte substrate preference switches from carbohydrates to fatty acids, and this is concurrent with the replacement of small, fetal mitochondria with morphologically distinct mature, adult mitochondria better suited to support the heightened energetic demand of mature cardiac muscle [16](#febs14336-bib-0016){ref-type="ref"}. Remarkably, mitophagy has been implicated in this maturation process: genetic disruption of mitophagy‐related signalling in mice results in fetal‐like mitochondria in adult animals, the development of progressive cardiomyopathy and death by 7--8 weeks of age [17](#febs14336-bib-0017){ref-type="ref"}.

Another example where developmentally induced mitochondrial changes occur in mitochondria is during the conversion of myoblasts into myotubes during skeletal muscle fibre development. Upon differentiation, when myoblasts ultimately fuse into multinucleated myofibres, their metabolic profile is reconfigured from glycolysis towards oxidative phosphorylation (OXPHOS) [18](#febs14336-bib-0018){ref-type="ref"}. Studies using cultured murine C2C12 myoblasts have shown that at this time, the mitochondrial population is initially cleared and then replenished with a structurally distinct network [19](#febs14336-bib-0019){ref-type="ref"}. Mitophagy is believed essential for this process and is, therefore, a potential key regulator of myogenesis [19](#febs14336-bib-0019){ref-type="ref"}.

Intriguingly, mitophagy itself can also promote glycolysis, a phenomenon first reported in cancer cells which can enhance mitophagy to upregulate glycolysis during prolonged mitotic arrest [20](#febs14336-bib-0020){ref-type="ref"}. A mitophagy‐triggered metabolic switch also occurs during the development of the embryonic mouse retina [21](#febs14336-bib-0021){ref-type="ref"}. In retinal ganglion cells (RGCs), the first retinal cell type to arise, differentiation occurs alongside a switch from OXPHOS to a highly glycolytic state. A block in mitophagy abrogates RGC differentiation and the associated bioenergetic changes, highlighting the pivotal role of mitophagy in this process [21](#febs14336-bib-0021){ref-type="ref"}.

Further elaborating on the fundamental importance of mitophagy, it has emerged as a key determinant for the maintenance of stem cell identity in embryonic stem cells, hematopoietic stem cells, and satellite cells, a population of muscle stem cells required for regeneration of skeletal muscle [22](#febs14336-bib-0022){ref-type="ref"}, [23](#febs14336-bib-0023){ref-type="ref"}, [24](#febs14336-bib-0024){ref-type="ref"}. Mitophagy is also an important feature of somatic cell reprogramming to induce pluripotent stem cells (iPSCs). Somatic cells and iPSCs have distinct metabolic identities, whereby somatic cells rely predominantly on OXPHOS and iPSCs are highly glycolytic. This metabolic shift is essential for reprogramming efficiency and is accompanied by a characteristic reduction in mitochondrial content [25](#febs14336-bib-0025){ref-type="ref"}. Critically, mitophagic activity accounts for the decrease in mitochondrial mass observed at the onset of somatic cell reprogramming and contributes to successful completion of iPSC generation [22](#febs14336-bib-0022){ref-type="ref"}, [26](#febs14336-bib-0026){ref-type="ref"}, [27](#febs14336-bib-0027){ref-type="ref"}.

Mechanistic basics for mitophagy initiation {#febs14336-sec-0003}
===========================================

Mitophagy is a mechanistically elaborate process and critically depends on the regulated convergence of multiple signalling events. The basic requirements for mitophagy are summarised in Fig. [1](#febs14336-fig-0001){ref-type="fig"}. These include (a) fission of the mitochondrial network to produce a suitably sized mitochondrion that can be readily engulfed by the forming autophagosome; (b) priming of the mitochondrion for recognition by the autophagy machinery; and (c) engulfment of the marked mitochondrion by the forming autophagosome. Whether these three steps occur independently and sequentially, or in combination, remains to be determined.

Fission {#febs14336-sec-0004}
-------

Mitochondrial dynamics are integral to mitochondrial function and the mechanics of mitophagy. Size constraints dictate that a typical mitochondrion cannot be accommodated within an autophagosome unless the network undergoes significant structural alteration. Mitochondrial fission refers to the severing of the mitochondrial network into smaller portions and is catalysed by the GTPase dynamin‐related protein 1 (Drp1) [28](#febs14336-bib-0028){ref-type="ref"}. At sites where endoplasmic reticulum (ER) tubules contact mitochondria, Drp1 is recruited from the cytosol by several adaptor proteins located at the surface of the organelle [29](#febs14336-bib-0029){ref-type="ref"}, [30](#febs14336-bib-0030){ref-type="ref"}, [31](#febs14336-bib-0031){ref-type="ref"}. Subsequent Drp1 oligomerisation and GTP hydrolysis leads to complete membrane constriction at fission sites [32](#febs14336-bib-0032){ref-type="ref"}. Importantly, fission commonly precedes and is necessary for mitophagy. Random fission events have been observed to generate two mitochondrial daughter units with uneven membrane potential [4](#febs14336-bib-0004){ref-type="ref"}. The fragments with diminished, unrecoverable membrane potential were unlikely to rejoin the mitochondrial network and more prone to turnover, thus providing a means to ensure the overall quality of the mitochondrial network [4](#febs14336-bib-0004){ref-type="ref"}. Conversely, it has also been shown that starvation‐induced elongation of the mitochondrial network spares mitochondria from degradation, enhancing OXPHOS potential during energy deprivation [33](#febs14336-bib-0033){ref-type="ref"}, [34](#febs14336-bib-0034){ref-type="ref"}. Enhanced mitochondrial connectivity has also been observed when mitochondrial OXPHOS is upregulated [35](#febs14336-bib-0035){ref-type="ref"}. Under these conditions, mitophagy is blocked as a direct consequence of defective mitochondrial fission [36](#febs14336-bib-0036){ref-type="ref"}.

It is essential to consider how the signals coordinating mitochondrial fission and mitophagy may be coupled. A direct role for the key mitophagy initiating kinase PTEN‐induced putative kinase 1 (PINK1), which is discussed in more detail below, has been proposed to play a role in this process. Following pharmacological agent‐induced depolarisation, PINK1 activity was shown to alleviate inhibitory protein kinase A (PKA)‐dependent Drp1 phosphorylation to promote fission [37](#febs14336-bib-0037){ref-type="ref"}. This is due to the displacement of PKA from AKAP1, a mitochondrial scaffolding protein that recruits PKA to the outer mitochondrial membrane (OMM), by an unknown mechanism. Another mitochondrial and mitophagy‐related protein, FUN‐14 domain containing protein 1 (FUNDC1), has been shown to instigate fission through direct physical association with Drp1. Wu *et al*. [38](#febs14336-bib-0038){ref-type="ref"} demonstrated that a shift to hypoxic conditions induces the relocation of FUNDC1 to mitochondria‐associated ER membranes (MAMs), where it binds the MAM protein calnexin. Longer exposure to hypoxia reduces the interaction between FUNDC1 and calnexin, with the latter eventually being replaced with Drp1. Research by Chen *et al*. [39](#febs14336-bib-0039){ref-type="ref"} showed that while Drp1 normally associates with the mitochondrial fusion factor OPA1, stress inducers such as selenite or carbonyl cyanide *p*‐(trifluoromethoxy)‐phenylhydrazon promote the binding of FUNDC1 to Drp1 instead.

The energy‐sensing kinase AMP‐activated protein kinase (AMPK) has strong links to mitochondrial function and has also been connected to mitochondrial dynamics [40](#febs14336-bib-0040){ref-type="ref"}. Upon its activation, either directly or through inhibition of the mitochondrial electron transport chain, AMPK phosphorylates mitochondrial fission factor (MFF) which increases mitochondrial Drp1 recruitment and subsequent fission. This is speculated to assist the mitophagic process.

Despite this, the mitophagy‐specific requirement of Drp1 has not been comprehensively established and alternate fission mechanisms may exist. Much work on the role of Drp1 in mitophagy has employed the use of mDivi1, a Drp1 small molecule inhibitor [41](#febs14336-bib-0041){ref-type="ref"}. Recent work suggests mDivi1 does not target Drp1 and instead functions as a mitochondrial complex I inhibitor [42](#febs14336-bib-0042){ref-type="ref"}. Additionally, there is mounting evidence for Drp1‐independent mitophagy [43](#febs14336-bib-0043){ref-type="ref"}, [44](#febs14336-bib-0044){ref-type="ref"}, [45](#febs14336-bib-0045){ref-type="ref"}. Remarkably, research from the Dorn laboratory revealed that mitophagy is actually promoted in the absence of Drp1 and inhibited in the absence of the fusion proteins Mfn1 and Mfn2 [44](#febs14336-bib-0044){ref-type="ref"}. While adding to the complexity of the situation, this nonetheless attests to the importance of mitochondrial dynamics to mitophagy. Elegant work from Yamashita *et al*. [45](#febs14336-bib-0045){ref-type="ref"} demonstrated an alternative scheme for mitochondrial fission upon mitophagy involving the autophagic machinery itself. They found that Drp1 is clearly absent from sites of autophagosome biogenesis at mitochondria and is dispensable for mitochondrial fission induced by a range of mitophagy stimuli. The autophagy machinery was first demonstrated to play a role in mitochondrial fission by the Chu Lab, which showed that siRNA of ATG7 or LC3 prevented mitochondrial fission in cells lacking PINK1 [46](#febs14336-bib-0046){ref-type="ref"}. Interestingly, Drp1 was also implicated in this fission, implying that Drp1‐dependent and autophagy‐dependent fission may operate independently and co‐operatively. However, the contexts of these fission events are far from clear, and it remains to be determined if different mitophagy pathways have differing mitochondrial fission requirements.

Priming mitochondria for mitophagy {#febs14336-sec-0005}
----------------------------------

The marking, or priming, of mitochondria for clearance is an essential step in mitophagy. Multiple factors, or receptors, have been identified which can orchestrate this by distinct mechanisms. Mitophagy receptors are central to mitochondrial priming and can be classified into two distinct groups; those which exist as integral mitochondrial proteins and those which indirectly associate with mitochondria through binding ubiquitylated mitochondrial proteins [47](#febs14336-bib-0047){ref-type="ref"}. All known protein mitophagy receptors possess a short, linear LC3‐interacting region (LIR) motif, which is responsible for their interaction with LC3/GABARAP proteins on the autophagosomal membrane. It consists of a core consensus sequence, as indicated by the single letter amino acid code: (W/F/Y)XX(L/I/V), where X can be any amino acid, and is often flanked by acidic residues [47](#febs14336-bib-0047){ref-type="ref"}.The LIR was first characterised in the ubiquitin‐binding protein p62/SQSTM1 as a critical determinant for the incorporation of polyubiquitylated aggregates into forming autophagosomes [48](#febs14336-bib-0048){ref-type="ref"}. Since this work, multiple LIR motif‐containing proteins have been identified and mediate the autophagy of various cargoes, in addition to mitochondria [49](#febs14336-bib-0049){ref-type="ref"}. Whether these receptors rely solely on their LIR motifs for cargo incorporation is not clear, but the receptors themselves are critical.

### PINK1/Parkin‐mediated mitophagy {#febs14336-sec-0006}

The most studied mitophagy pathway to date is mediated by the products of two genes that are mutated in autosomal recessive forms of Parkinson\'s disease (PD) [50](#febs14336-bib-0050){ref-type="ref"}, [51](#febs14336-bib-0051){ref-type="ref"}. Specifically, the mitochondrial‐associated protein kinase PINK1 and cytosolic RBR E3‐ubiquitin ligase Parkin play critical roles in damage‐induced mitophagy (see [3](#febs14336-bib-0003){ref-type="ref"}, [52](#febs14336-bib-0052){ref-type="ref"}, [53](#febs14336-bib-0053){ref-type="ref"} for the landmark papers and reviewed in [54](#febs14336-bib-0054){ref-type="ref"}). Under basal or steady‐state conditions, cellular PINK1 levels remain low due to constitutive processing at mitochondria prior to subsequent N‐end rule degradation [55](#febs14336-bib-0055){ref-type="ref"}. PINK1 acts as a molecular sensor of mitochondrial damage; mitochondrial membrane depolarisation inhibits PINK1 cleavage and degradation, leading to its accumulation on the OMM. PINK1 stabilisation is associated with enhanced kinase activity, dimerisation and autophosphorylation [56](#febs14336-bib-0056){ref-type="ref"}, [57](#febs14336-bib-0057){ref-type="ref"}, [58](#febs14336-bib-0058){ref-type="ref"}, [59](#febs14336-bib-0059){ref-type="ref"}. The subsequent recruitment of cytosolic Parkin to mitochondria is dependent on PINK1 activation [52](#febs14336-bib-0052){ref-type="ref"}, [59](#febs14336-bib-0059){ref-type="ref"}, [60](#febs14336-bib-0060){ref-type="ref"}, [61](#febs14336-bib-0061){ref-type="ref"}, [62](#febs14336-bib-0062){ref-type="ref"}. Parkin exists in an auto‐inhibited conformation mediated by intra‐molecular interactions within its UBL domain [63](#febs14336-bib-0063){ref-type="ref"}, [64](#febs14336-bib-0064){ref-type="ref"}. PINK1‐mediated phosphorylation of both Parkin [57](#febs14336-bib-0057){ref-type="ref"}, [65](#febs14336-bib-0065){ref-type="ref"} and ubiquitin at their respective serine 65 residues is necessary for full Parkin activation [66](#febs14336-bib-0066){ref-type="ref"}, [67](#febs14336-bib-0067){ref-type="ref"}, [68](#febs14336-bib-0068){ref-type="ref"}. Parkin catalyses the *de novo* conjugation and elongation of pre‐existing ubiquitin chains onto a host of OMM proteins, which are predicted to serve as PINK1 substrates [66](#febs14336-bib-0066){ref-type="ref"}, [67](#febs14336-bib-0067){ref-type="ref"}, [68](#febs14336-bib-0068){ref-type="ref"}. This increase in phospho‐ubiquitin chains on depolarised mitochondria constitutes a feed‐forward amplification loop that results in the completion of mitophagy [69](#febs14336-bib-0069){ref-type="ref"}, [70](#febs14336-bib-0070){ref-type="ref"}, [71](#febs14336-bib-0071){ref-type="ref"}. It is important to note that Parkin is not the only E3 ubiquitin ligase that has been implicated in mitophagy, with ligases such as MUL1 possibly performing a similar role [14](#febs14336-bib-0014){ref-type="ref"}. Additionally, ubiquitylation itself is reversible and deubiquitylases have thus been shown to be negative regulators of mitophagy [72](#febs14336-bib-0072){ref-type="ref"}.

Ubiquitylation of OMM proteins enables the recruitment of mitophagy receptors which possess a ubiquitin‐binding domain in addition to a LIR motif. These include p62/SQSTM1, OPTN, NDP52, TAX1BP1 and NBR1 [73](#febs14336-bib-0073){ref-type="ref"}. Utilisation of genome‐editing technology has revealed that NDP52 and OPTN are the essential receptors for mitophagy, with a lesser contribution from TAX1BP1, while NBR1 and p62 are dispensable [74](#febs14336-bib-0074){ref-type="ref"}, [75](#febs14336-bib-0075){ref-type="ref"}. Surprisingly, OPTN and NDP52 are recruited to mitochondria even in the absence of Parkin and mitochondrial damage, and this is sufficient to induce mitophagy, albeit at a very low level [74](#febs14336-bib-0074){ref-type="ref"}.

Recently, the Levine laboratory identified prohibitin 2 (PHB2) as the first inner mitochondrial membrane (IMM) mitophagy receptor, which they found to be required for Parkin‐dependent mitophagy [76](#febs14336-bib-0076){ref-type="ref"}. In Parkin‐overexpressing cells subject to mitochondrial damaging agents, proteasomal degradation of the OMM makes IMM components accessible. Successful mitophagy relies on an interaction between PHB2 and LC3 via its LIR [76](#febs14336-bib-0076){ref-type="ref"}. Taken together, this suggests that a combination of mitophagy receptors is required for efficient mitochondrial priming.

Although much of the experimental evidence obtained to date supports the notion that PINK1 and Parkin are involved in damage‐induced mitophagy, this pathway has also been implicated in the regulation of programmed mitophagy. Indeed, the previously mentioned mitophagy that occurs during cardiomyocyte development is described to be PINK1/Parkin‐dependent [17](#febs14336-bib-0017){ref-type="ref"}.

### BNIP3 and NIX/BNIP3L {#febs14336-sec-0007}

Collectively, the findings amassed to date undoubtedly substantiate the importance of PINK1 and Parkin as central regulators of mitophagy. However, multiple other mitophagy pathways exist in addition. Indeed, our overall understanding of mitophagy has been propelled by evidence demonstrating that mitophagy is also mediated by receptors constitutively localised to mitochondria in a PINK1/Parkin‐independent manner. The hypoxia‐inducible proteins BNIP3L/NIX and its closely related homologue BNIP3 were the first mammalian mitophagy receptors identified [7](#febs14336-bib-0007){ref-type="ref"}, [8](#febs14336-bib-0008){ref-type="ref"}, [77](#febs14336-bib-0077){ref-type="ref"}. They were first characterised as pro‐apoptotic BH3‐only Bcl‐2 family proteins, both localised to the OMM by way of a C‐terminal transmembrane domain [78](#febs14336-bib-0078){ref-type="ref"}. Both NIX and BNIP3 contain identical LIRs at their N termini which facilitate interaction with autophagosomal LC3/GABARAP proteins [79](#febs14336-bib-0079){ref-type="ref"}. Both NIX and BNIP3 have been implicated in mitophagy; however, currently NIX is the most widely studied of the two proteins.

The mitophagic role of NIX was first illustrated in the context of erythropoiesis. NIX, which is transcriptionally upregulated during erythroid differentiation, is essential for mitochondrial clearance via mitophagy during the terminal stages of this process [7](#febs14336-bib-0007){ref-type="ref"}, [8](#febs14336-bib-0008){ref-type="ref"}, [80](#febs14336-bib-0080){ref-type="ref"}. Strikingly, in erythrocytes from NIX‐deficient mice, mitochondria fail to be incorporated into autophagosomes, implying that NIX is critical for recruitment [7](#febs14336-bib-0007){ref-type="ref"}, [8](#febs14336-bib-0008){ref-type="ref"}. Ablation of NIX interrupts erythroid maturation, resulting in anaemia, reticulocytosis and erythroid‐myeloid hyperplasia.

Besides erythroid differentiation, NIX is also the receptor required for mitophagy during somatic cell reprogramming to iPSCs and for RGC differentiation [21](#febs14336-bib-0021){ref-type="ref"}, [26](#febs14336-bib-0026){ref-type="ref"}. During RGC differentiation, local hypoxia transcriptionally induces NIX, accumulation of which triggers both mitochondrial removal and activation of glycolysis. Retinas from mice lacking NIX retain their mitochondria and exhibit fewer RGCs [21](#febs14336-bib-0021){ref-type="ref"}.

NIX is also involved in mitophagy induced when the demand for mitochondrial OXPHOS is high [81](#febs14336-bib-0081){ref-type="ref"}. In these circumstances, the small GTPase Rheb is recruited to the OMM where it is proposed to stimulate mitophagy through binding NIX and recruiting LC3 [81](#febs14336-bib-0081){ref-type="ref"}. Accelerated rejuvenation of the mitochondrial pool is believed to contribute to increased OXPHOS efficiency.

A role for BNIP3 and mitophagy has been implicated in cancer development. In a mouse model of mammary tumorigenesis, loss of BNIP3 resulted in reduced mitophagy, the accumulation of functionally impaired mitochondria, elevated ROS production and consequent stabilisation of HIF1α [82](#febs14336-bib-0082){ref-type="ref"}. Increased HIF1α target gene expression favoured angiogenesis and bioenergetic changes associated with Warburg metabolism that ultimately promoted invasiveness and metastasis.

Although BNIP3 and NIX are primarily under transcriptional control, their mitophagic activity is also activated by post‐translational modification. Phosphorylation by an unknown kinase adjacent to the LIR of NIX and BNIP3 strengthens the association with LC3 to enhance mitophagy [83](#febs14336-bib-0083){ref-type="ref"}, [84](#febs14336-bib-0084){ref-type="ref"}.

### FUNDC1 {#febs14336-sec-0008}

FUNDC1, an OMM‐spanning protein with an N‐terminal LIR motif, is another mitophagy receptor which functions independently of the PINK1/Parkin axis, and is responsible for hypoxia‐induced mitophagy [85](#febs14336-bib-0085){ref-type="ref"}. Short‐term regulation of FUNDC1 is carefully controlled by its phosphorylation status. In unstressed conditions, FUNDC1 is phosphorylated by Src kinase at tyrosine 18 and CK2 at serine 13, blocking its interaction with LC3 [85](#febs14336-bib-0085){ref-type="ref"}, [86](#febs14336-bib-0086){ref-type="ref"}. PGAM5 is a mitochondrially localised phosphatase capable of dephosphorylating FUNDC1 at serine 13 [86](#febs14336-bib-0086){ref-type="ref"}. Its activity is usually held in check through inhibitory interaction with Bcl‐xL; however, Bcl‐xL is degraded upon hypoxic stress, thereby enhancing PGAM5 phosphatase activity and promoting the targeting of mitochondria to LC3‐decorated autophagosomes for engulfment [87](#febs14336-bib-0087){ref-type="ref"}. The interaction between FUNDC1 and LC3 can be further strengthened following UNC‐51‐like kinase 1 (ULK1)‐dependent phosphorylation of FUNDC1 at serine 17 [88](#febs14336-bib-0088){ref-type="ref"}. Beyond phosphorylation, ubiquitylation has also been implicated as a FUNDC1 control mechanism [89](#febs14336-bib-0089){ref-type="ref"}. The OMM‐localised E3 ligase MARCH5 can ubiquitylate FUNDC1 at the early stages of hypoxia, before FUNDC1 dephosphorylation, to prevent excessive mitophagy [89](#febs14336-bib-0089){ref-type="ref"}.

### Bcl2L13 {#febs14336-sec-0009}

Bcl2L13, first identified as a pro‐apoptotic and atypical Bcl2 family member [90](#febs14336-bib-0090){ref-type="ref"}, is another OMM‐anchored mitophagy receptor which can recruit LC3/GABARAP proteins to mitochondria during mitophagy [43](#febs14336-bib-0043){ref-type="ref"}. Interestingly, this study showed that Bcl2L13 is multifunctional with respect to mitophagy as it mediates both mitochondrial fission and mitophagy upon mitochondrial damage. While the BH2 domains of Bcl2L13 were required for mitochondrial fragmentation, mutation of its internal LIR motif precludes association with LC3. Thus, both BH2 and LIR domains appear vital for mitophagy.

### FKBP8 {#febs14336-sec-0010}

FKBP8/FKBP38 is a unique member of the FK506 family of binding proteins, distinguished by the fact that it possesses Ca^2+^/calmodulin‐activated peptidyl‐prolyl cis‐trans isomerase activity. It has been linked to multiple cellular processes including apoptosis and regulation of mTOR [91](#febs14336-bib-0091){ref-type="ref"}. Among the known mitophagy receptors in the OMM, FKBP8 is unique in that it itself avoids mitophagic turnover by rerouting to the ER [92](#febs14336-bib-0092){ref-type="ref"}, [93](#febs14336-bib-0093){ref-type="ref"}. While solid evidence of endogenous FKBP8 participating in mitophagy is lacking, it has been demonstrated that Parkin‐independent mitophagy ensues upon overexpression of both LC3 and FKBP8. The exact mechanism by which FKBP8 escapes degradation is unclear, as are the reasons for this intriguing behaviour, although it depends on a number of basic residues within its C‐terminal sequence [92](#febs14336-bib-0092){ref-type="ref"}, [93](#febs14336-bib-0093){ref-type="ref"}.

### Cardiolipin {#febs14336-sec-0011}

Protein receptors are not the only mode of mitophagy priming. The mitochondrially localised and unique anionic phospholipid cardiolipin (CL) can also act as a receptor. CL is unusual in that it is almost exclusively confined to the IMM. Here, it is an important regulator of mitochondrial bioenergetics, as association between CL and electron transport chain components is required for their optimal activity [94](#febs14336-bib-0094){ref-type="ref"}. Exposure to a range of mitophagic stimuli has also been shown to cause translocation of CL to the OMM, where it is free to interact with the N‐terminal of LC3 to facilitate capture of the mitochondrion into the forming autophagosome [95](#febs14336-bib-0095){ref-type="ref"}. The translocation of CL to the OMM was recently shown to require NDPK‐D, an intermembrane space‐localised nucleoside diphosphate kinase, which binds CL following mitophagy induction [96](#febs14336-bib-0096){ref-type="ref"}. CL has also been shown to regulate mitochondrial fission and fusion through recruitment and activation of Drp1 and OPA1; therefore, it may play multiple roles in mitophagy [97](#febs14336-bib-0097){ref-type="ref"}, [98](#febs14336-bib-0098){ref-type="ref"}, [99](#febs14336-bib-0099){ref-type="ref"}. Additionally, other lipids may also play an important role in regulating mitophagy [100](#febs14336-bib-0100){ref-type="ref"}.

While we have discussed the various mitochondrial receptors individually, it is possible that they do not operate in isolation. For example, there is evidence to support the idea that crosstalk exists between PINK1/Parkin‐mediated mitophagy and OMM receptor‐mediated mitophagy pathways [101](#febs14336-bib-0101){ref-type="ref"}, [102](#febs14336-bib-0102){ref-type="ref"}, [103](#febs14336-bib-0103){ref-type="ref"}. However, it has been clearly demonstrated that NIX‐mediated mitophagy is active even in the absence of a functional PINK1/Parkin pathway, as overexpression of NIX in human fibroblasts, isolated from patients with Parkin or PINK1‐related early‐onset PD, was capable of restoring carbonyl cyanide m‐chlorophenylhydrazone‐induced mitophagy [104](#febs14336-bib-0104){ref-type="ref"}. While potential crosstalk cannot be ruled out, its nature and regulation require further investigation.

Mitochondrial engulfment by the autophagy machinery {#febs14336-sec-0012}
---------------------------------------------------

Coincident with marking mitochondria for degradation, the autophagy machinery must be activated to drive formation of the engulfing autophagosome. While the relevant upstream signalling events are well defined in the context of classical starvation‐induced autophagy (reviewed in [105](#febs14336-bib-0105){ref-type="ref"}, [106](#febs14336-bib-0106){ref-type="ref"}, [107](#febs14336-bib-0107){ref-type="ref"}), the sensing mechanisms and signals that set the stage for targeted mitophagy induction are less clear.

### Autophagy activating signals {#febs14336-sec-0013}

At the helm of the canonical starvation‐induced autophagy pathway is the ULK1 protein kinase complex (comprising ULK1, ATG13, FIP200 and ATG101). ULK1 complex activation is essential for the early stages of autophagosome biogenesis [105](#febs14336-bib-0105){ref-type="ref"} and as such has been implicated in both programmed and damage‐induced mitophagy. With respect to the former, ULK1 knockout (KO) mice display impaired removal during reticulocyte development [108](#febs14336-bib-0108){ref-type="ref"}, [109](#febs14336-bib-0109){ref-type="ref"}. As for the latter, ULK1 has also been shown to be critical for mitochondrial clearance in the PINK1/Parkin‐mediated pathway [74](#febs14336-bib-0074){ref-type="ref"}, [110](#febs14336-bib-0110){ref-type="ref"} as well as during hypoxia [88](#febs14336-bib-0088){ref-type="ref"}.

#### mTORC1‐ULK1 {#febs14336-sec-0014}

The major negative regulator of canonical autophagy is the nutrient‐sensing protein kinase complex mammalian target of rapamycin complex 1 (mTORC1). In nutrient replete conditions, active mTORC1 restrains autophagic induction through inhibitory phosphorylation of ULK1 [105](#febs14336-bib-0105){ref-type="ref"}. Repression of mTORC1 and dephosphorylation of ULK1 is essential for the activation of autophagy. In terms of mitophagy, there has been only limited analysis of the mTORC1 signalling pathway. In cybrid cells depleted of mtDNA, but not in wild‐type counterparts, mitophagy is provoked using the mTORC1 inhibitor rapamycin in conjunction with mitochondrial depolarisation [111](#febs14336-bib-0111){ref-type="ref"}. In line with this, during neurogenesis, rapamycin treatment has also been observed to induce mitophagy and promote RGC differentiation [21](#febs14336-bib-0021){ref-type="ref"}. Conflictingly, mitophagy mediated by Rheb under OXPHOS‐dependent conditions occurs in the absence of mTORC1 deactivation [81](#febs14336-bib-0081){ref-type="ref"}. Further work is obviously needed to clarify the role of the ULK1‐mTORC1 axis during mitophagy stimulation.

#### AMPK‐ULK1 {#febs14336-sec-0015}

Along with mTORC1, AMPK plays a significant role in regulating ULK1 activity in general autophagy. Multiple studies have identified AMPK‐dependent phosphorylation sites within ULK1 [112](#febs14336-bib-0112){ref-type="ref"}, [113](#febs14336-bib-0113){ref-type="ref"}, [114](#febs14336-bib-0114){ref-type="ref"}, [115](#febs14336-bib-0115){ref-type="ref"}, [116](#febs14336-bib-0116){ref-type="ref"}. However, with varying overlap in sites identified between studies, and both activating and inhibitory effects reported, the relationship between AMPK and ULK1 remains obscure.

Consistent with a functional connection between AMPK and ULK1, mitochondrial removal is suppressed during the terminal differentiation of erythrocytes from AMPKα1 KO mice [117](#febs14336-bib-0117){ref-type="ref"}. It has also been reported that upon hypoxia, AMPK directly phosphorylates ULK1 at S555 [118](#febs14336-bib-0118){ref-type="ref"}. This triggers ULK1 translocation to mitochondria and is critical for mitophagic induction. As mentioned previously, AMPK has been shown to regulate mitochondrial fission [40](#febs14336-bib-0040){ref-type="ref"} and this opens up the possibility that AMPK coordinates multiple steps of mitophagy induction.

### Recruitment of the autophagy machinery by mitophagy receptors {#febs14336-sec-0016}

The long‐held notion is that a key function of the mitophagy receptors is to recruit a forming autophagosome to the mitochondrion via their ability to bind the autophagosomal LC3/GABARAP proteins. However, this may not be the only role the receptors play, with evidence suggesting that they may function earlier at the autophagosome initiation stage. Autophagosome generation is believed to be initiated at the mitochondrion itself and mitochondrial recruitment of upstream autophagy factors, including ULK1, DFCP1 and ATG14, has been shown to occur in the absence of LC3 [45](#febs14336-bib-0045){ref-type="ref"}, [110](#febs14336-bib-0110){ref-type="ref"}. Indeed, during mitophagy, there does not seem to be an absolute requirement for LC3/GABARAP proteins in autophagosome formation [119](#febs14336-bib-0119){ref-type="ref"}, [120](#febs14336-bib-0120){ref-type="ref"}. Instead, recent observations suggest that LC3 functions at the autophagosome‐lysosome fusion step and can mediate the subsequent degradation of the inner autophagosomal membrane [119](#febs14336-bib-0119){ref-type="ref"}, [120](#febs14336-bib-0120){ref-type="ref"}. Therefore, receptor interaction with the autophagy signalling machinery may be key.

In the case of PINK1/Parkin‐dependent mitophagy, recruitment of the autophagy machinery to mitochondria has been reported to occur downstream of mitochondrial priming. Although ULK1 regulation by AMPK and mTORC1 occurs independently to the core mitophagy receptors OPTN and NDP52, they are thought to be indispensable for ULK1 recruitment to mitochondria [74](#febs14336-bib-0074){ref-type="ref"}. The subsequent recruitment of LC3, WIPI1 and DFCP1 is thus also reliant on both OPTN and NDP52.

Notably, FUNDC1 was also proposed to be a mitochondrial receptor for ULK1 [88](#febs14336-bib-0088){ref-type="ref"}. In this hypoxia‐induced mitophagy pathway, ULK1 translocation to mitochondria is dependent on FUNDC1, and their association is necessary to accomplish mitochondrial degradation [88](#febs14336-bib-0088){ref-type="ref"}.

As is summarised in Table [1](#febs14336-tbl-0001){ref-type="table-wrap"}, a complex molecular picture of mitophagy is emerging with multiple mechanisms proposed to regulate both damage‐induced and programmed mitophagy. However, most of these mechanistic insights have been derived from cultured cell lines treated under nonphysiological conditions. Therefore, the major future challenge is to determine when and where these pathways operate *in vivo*.

###### 

Proteins involved in the different stages of mitophagy induction

  Protein                   Function                                         References
  ------------------------- ------------------------------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Stage of mitophagy                                                         
  Fission                                                                    
  Drp1                      Dynamin‐related GTPase                           [37](#febs14336-bib-0037){ref-type="ref"}, [38](#febs14336-bib-0038){ref-type="ref"}, [39](#febs14336-bib-0039){ref-type="ref"}, [40](#febs14336-bib-0040){ref-type="ref"}, [46](#febs14336-bib-0046){ref-type="ref"}
  PINK1                     Mitochondrial protein kinase                     [37](#febs14336-bib-0037){ref-type="ref"}
  PKA                       Multifunctional protein kinase                   [37](#febs14336-bib-0037){ref-type="ref"}
  AKAP                      Mitochondrial PKA scaffolding protein            [37](#febs14336-bib-0037){ref-type="ref"}
  AMPK                      Energy‐sensing protein kinase                    [40](#febs14336-bib-0040){ref-type="ref"}
  MFF                       DRP1‐interacting mitochondrial protein           [40](#febs14336-bib-0040){ref-type="ref"}
  FUNDC1                    Mitophagy receptor                               [38](#febs14336-bib-0038){ref-type="ref"}, [39](#febs14336-bib-0039){ref-type="ref"}
  BCL2L13                   Mitophagy receptor                               [43](#febs14336-bib-0043){ref-type="ref"}
  FIP200/ATG14/WIPI2/ATG7   Autophagy initiation machinery                   [45](#febs14336-bib-0045){ref-type="ref"}, [46](#febs14336-bib-0046){ref-type="ref"}
  CL                        Mitochondrial phospholipid                       [96](#febs14336-bib-0096){ref-type="ref"}, [97](#febs14336-bib-0097){ref-type="ref"}, [98](#febs14336-bib-0098){ref-type="ref"}
  Priming                                                                    
  PINK1                     Mitochondrial protein kinase                     [52](#febs14336-bib-0052){ref-type="ref"}, [53](#febs14336-bib-0053){ref-type="ref"}, [54](#febs14336-bib-0054){ref-type="ref"}
  Parkin                    E3 ubiquitin ligase                              [3](#febs14336-bib-0003){ref-type="ref"}, [54](#febs14336-bib-0054){ref-type="ref"}
  Phospho‐ubiquitin         PINK1 substrate                                  [66](#febs14336-bib-0066){ref-type="ref"}, [67](#febs14336-bib-0067){ref-type="ref"}, [68](#febs14336-bib-0068){ref-type="ref"}
  p62                       Ubiquitin‐binding autophagy/mitophagy receptor   [73](#febs14336-bib-0073){ref-type="ref"}, [74](#febs14336-bib-0074){ref-type="ref"}, [75](#febs14336-bib-0075){ref-type="ref"}
  OPTN                      Ubiquitin‐binding autophagy/mitophagy receptor   [73](#febs14336-bib-0073){ref-type="ref"}, [74](#febs14336-bib-0074){ref-type="ref"}, [75](#febs14336-bib-0075){ref-type="ref"}
  NDP52                     Ubiquitin‐binding autophagy/mitophagy receptor   [73](#febs14336-bib-0073){ref-type="ref"}, [74](#febs14336-bib-0074){ref-type="ref"}, [75](#febs14336-bib-0075){ref-type="ref"}
  NBR1                      Ubiquitin‐binding autophagy/mitophagy receptor   [73](#febs14336-bib-0073){ref-type="ref"}, [74](#febs14336-bib-0074){ref-type="ref"}
  TAX1BP1                   Ubiquitin‐binding autophagy/mitophagy receptor   [73](#febs14336-bib-0073){ref-type="ref"}, [74](#febs14336-bib-0074){ref-type="ref"}
  PHB2                      Mitophagy receptor                               [76](#febs14336-bib-0076){ref-type="ref"}
  NIX                       Mitophagy receptor                               [7](#febs14336-bib-0007){ref-type="ref"}, [8](#febs14336-bib-0008){ref-type="ref"}, [21](#febs14336-bib-0021){ref-type="ref"}, [26](#febs14336-bib-0026){ref-type="ref"}, [81](#febs14336-bib-0081){ref-type="ref"}
  Rheb                      mTOR‐activating GTPase                           [81](#febs14336-bib-0081){ref-type="ref"}
  BNIP3                     Mitophagy receptor                               [82](#febs14336-bib-0082){ref-type="ref"}, [83](#febs14336-bib-0083){ref-type="ref"}
  FUNDC1                    Mitophagy receptor                               [85](#febs14336-bib-0085){ref-type="ref"}, [86](#febs14336-bib-0086){ref-type="ref"}, [87](#febs14336-bib-0087){ref-type="ref"}, [88](#febs14336-bib-0088){ref-type="ref"}, [89](#febs14336-bib-0089){ref-type="ref"}
  PGAM5                     Mitochondrial protein phosphatase                [86](#febs14336-bib-0086){ref-type="ref"}, [87](#febs14336-bib-0087){ref-type="ref"}
  CK2                       Protein kinase                                   [86](#febs14336-bib-0086){ref-type="ref"}
  Src                       Tyrosine protein kinase                          [85](#febs14336-bib-0085){ref-type="ref"}, [86](#febs14336-bib-0086){ref-type="ref"}
  MARCH5                    Mitochondrial E3 ubiquitin ligase                [89](#febs14336-bib-0089){ref-type="ref"}
  ULK1                      Autophagy‐initiating protein kinase              [88](#febs14336-bib-0088){ref-type="ref"}
  BCL2L13                   Mitophagy receptor                               [43](#febs14336-bib-0043){ref-type="ref"}
  FKBP8                     Mitophagy receptor                               [92](#febs14336-bib-0092){ref-type="ref"}, [93](#febs14336-bib-0093){ref-type="ref"}
  CL                        Mitochondrial phospholipid                       [95](#febs14336-bib-0095){ref-type="ref"}, [96](#febs14336-bib-0096){ref-type="ref"}
  Engulfment                                                                 
  ULK1                      Autophagy‐initiating protein kinase              [73](#febs14336-bib-0073){ref-type="ref"}, [74](#febs14336-bib-0074){ref-type="ref"}, [88](#febs14336-bib-0088){ref-type="ref"}, [108](#febs14336-bib-0108){ref-type="ref"}, [109](#febs14336-bib-0109){ref-type="ref"}, [110](#febs14336-bib-0110){ref-type="ref"}
  mTORC1                    Nutrient‐sensing protein kinase                  [21](#febs14336-bib-0021){ref-type="ref"}, [81](#febs14336-bib-0081){ref-type="ref"}, [111](#febs14336-bib-0111){ref-type="ref"}
  AMPK                      Energy‐sensing protein kinase                    [112](#febs14336-bib-0112){ref-type="ref"}, [113](#febs14336-bib-0113){ref-type="ref"}, [114](#febs14336-bib-0114){ref-type="ref"}, [115](#febs14336-bib-0115){ref-type="ref"}, [116](#febs14336-bib-0116){ref-type="ref"}
  OPTN                      Mitophagy receptor                               [73](#febs14336-bib-0073){ref-type="ref"}
  NDP52                     Mitophagy receptor                               [73](#febs14336-bib-0073){ref-type="ref"}
  FUNDC1                    Mitophagy receptor                               [88](#febs14336-bib-0088){ref-type="ref"}
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Investigating mammalian mitophagy *in vivo* {#febs14336-sec-0017}
===========================================

It has proved challenging to evaluate the physiological significance of numerous *in vitro* observations pertaining to mitophagy. This was due to a distinct lack of tools that facilitate the reliable detection of mammalian mitophagy *in vivo*. Recently, two mouse models have been described that utilise fluorescent reporter systems to enable the detection of mitophagy *in vivo* (*mito*‐QC reported by [121](#febs14336-bib-0121){ref-type="ref"} and mt‐Keima reported by [122](#febs14336-bib-0122){ref-type="ref"}). These models exploit the acid labile properties of fluorescent reporter proteins to provide end‐point readouts of mitophagy *in vivo*. As such, the readout of mitophagy in the context of the current *in vivo* reporters is defined in terms of mitochondrial delivery to the acidic microenvironment of the lysosome. Under these conditions, the acidity either quenches the GFP signal (in the case of *mito*‐QC) or shifts the excitation wavelength (in the case of mt‐Keima, see Fig. [2](#febs14336-fig-0002){ref-type="fig"}). Both reporters faithfully monitor mitophagy and are ubiquitously expressed, though from different loci (*Rosa26* for *mito*‐QC and *Hip11* for mt‐Keima). As the reporters monitor the end‐point of mitophagy, they do not distinguish between distinct mitophagic pathways. However, the reporters localise to different mitochondrial compartments: mitochondrial outer membrane localisation for *mito*‐QC versus matrix localisation for mt‐Keima. This localisation is important as it may help distinguish between the previously mentioned MDV pathway, which represents an alternate mode of mitochondrial protein delivery to lysosomes [1](#febs14336-bib-0001){ref-type="ref"}. In contrast to mt‐Keima, the MOM topology of *mito*‐QC means that it will never be delivered to the lysosomal lumen through the more classical transport mechanism of the MDV pathway -- hence, the mCherry‐only signal cannot be a consequence of this. Another model termed MitoTimer has also been described [123](#febs14336-bib-0123){ref-type="ref"}; however, this is an inducible model designed to monitor mitochondrial biogenesis over time, as well as mitophagy. Differences between these models are illustrated in Fig. [2](#febs14336-fig-0002){ref-type="fig"}, and these have also been recently reviewed [124](#febs14336-bib-0124){ref-type="ref"}. Regardless, these collective advances have transformed the landscape of mammalian mitophagy, enabling the interrogation of mitophagy and mitochondrial homeostasis in a variety of physiological contexts [54](#febs14336-bib-0054){ref-type="ref"}, [125](#febs14336-bib-0125){ref-type="ref"}.

![Mitophagy reporters. Schematic detailing the different reporters used to monitor mitophagy. In *mito*‐QC, a tandem mCherry‐GFP tag is targeted to the OMM. Under normal cytosolic conditions the mitochondria display both mCherry and GFP fluorescence. However, upon mitophagy, the low pH of the mitochondrion‐containing lysosome (mitolysosome) is sufficient to quench the GFP, but not mCherry, signal. In mt‐Keima, monomeric Keima protein is targeted to the mitochondrial matrix. Under normal cytosolic conditions, mt‐Keima is excited by light peaking at 400 nm, whereas this increases to 568 nm under lysosomal conditions, i.e. upon mitophagy. mt‐Keima\'s emission spectra remains the same, at 620 nm, regardless of this pH shift. For MitoTimer, the fluorophore DsRed1‐E5 was targeted to the mitochondrial matrix. Though strictly not designed to monitor mitophagy, it provides a powerful way in which to monitor the age of mitochondria as fluorescence shifts from green to red over a period of 48 h.](FEBS-285-1185-g002){#febs14336-fig-0002}

Basal mitophagy as a pervasive yet heterogeneous process in tissues {#febs14336-sec-0018}
-------------------------------------------------------------------

Perhaps, the most surprising conceptual discovery arising from these models is converging data that demonstrate the basal nature of mitophagy *in vivo*. Although differences in these models are well described [121](#febs14336-bib-0121){ref-type="ref"}, both studies report highly pervasive instances of mitophagy under normal everyday conditions. This is in stark contrast to the still widely held perception of mitophagy as merely an 'activated autophagy response' triggered to mitigate mitochondrial meltdown. This raises several important and unanswered questions: what are the tissue‐specific regulators of basal mitophagy *in vivo*? Do any of the aforementioned effectors of stimulus‐induced mitophagy modulate basal homeostatic mitophagy *in vivo*? Does disruption of these basal pathways have any pathophysiological consequences?

Basal mitophagy and metabolic context {#febs14336-sec-0019}
-------------------------------------

Although both mitophagy models revealed an extensive amount of basal mitophagy, studies using *mito*‐QC have highlighted the striking heterogeneity in mitophagy levels between defined cellular subsets *in vivo*. Thus, while all organ systems exhibit some degree of mitochondrial turnover, not all cells exhibit comparable levels of mitophagy *in vivo*. This is particularly evident in organ systems of high metabolic demand such as the nervous system, the renal system and cardiovascular system. In the brain, Sun *et al*. [122](#febs14336-bib-0122){ref-type="ref"} were able to demonstrate regionalised instances of mitophagy in unlabelled tissue. However, given the breathtaking morphological complexity and diversity of neural subtypes, a more precise analysis is required to accurately interpret such observations in anisotropic tissue. Using *mito*‐QC combined with immunohistochemistry and high‐resolution microscopy, McWilliams *et al*. [121](#febs14336-bib-0121){ref-type="ref"} showed specifically that labelled cerebellar Purkinje neurons exhibit robust levels of mitophagy, which was largely enriched within the somata. Future work will be essential to determine the spatial profile and regulation of mitophagy in different neuronal and nonneuronal subtypes. Furthermore, could basal mitophagy be elevated or diminished in genetic models of neurodegenerative disease? Interestingly, Sun *et al*. demonstrated diminished mitophagy in the context of Huntingtin overexpression [122](#febs14336-bib-0122){ref-type="ref"}. PINK1/Parkin signalling has gained much attention in stimulated mitophagy pathways; however, we have no idea if this signalling influences basal mitophagy *in vivo*. Interrogating this signalling is also troublesome, due to lack of reliable tools available to robustly detect endogenous PINK1 protein at basal levels *in vivo*. The requirement of endogenous Parkin under conditions of chronic mitochondrial stress was elegantly demonstrated by the Youle laboratory, who observed progressive age‐dependent DA neurodegeneration in Parkin KO mice crossed with the mutator (*Polg* ^D257A^) mouse model [126](#febs14336-bib-0126){ref-type="ref"}. However, it remains unclear if dysregulated mitophagy lies at the root of pathology in the double‐mutant mice. Understanding mitophagy in a mouse model exhibiting symptomatic neurodegeneration will prove vital to the interpretation of dysregulated mitophagy and its contribution to the progression of diseases such as PD.

Outside of the nervous system, renal tubules exhibit a high metabolic demand. This requirement is in large part to drive the massive salt and protein reabsorption from the filtrate. As a consequence of this, these postmitotic tubular cells are second only to heart cardiomyocytes in terms of their mitochondrial content [127](#febs14336-bib-0127){ref-type="ref"}. It is, therefore, not surprising that impaired mitophagy has been postulated to contribute to a range of renal pathologies, including acute kidney injury [128](#febs14336-bib-0128){ref-type="ref"}, [129](#febs14336-bib-0129){ref-type="ref"}. It should not be overlooked that exactly 60 years ago, scientists described perhaps the first instances of mitophagy by observing degraded mitochondria within lysosome‐like structures in rabbit kidney tubules [130](#febs14336-bib-0130){ref-type="ref"}. In wild‐type *mito*‐QC animals, a striking level of mitophagy was observed throughout the cortex of the adult kidney (see Fig. [3](#febs14336-fig-0003){ref-type="fig"} and [121](#febs14336-bib-0121){ref-type="ref"}). However, a clear difference in the degree of mitophagy was observed between distinct tubules of the nephron. Proximal convoluted tubules (PCTs) exhibited a major enrichment in mitophagy compared with distal convoluted tubules (DCTs), even though both types of tubule are loaded with mitochondria. This discovery highlighted another important conceptual advance: that the degree of mitophagy within a cell is independent from its mitochondrial mass. What then might account for the heterogeneity of this basal mitophagy observed *in vivo*? Metabolic context is likely to play important role. For example, differences in adult renal mitophagy could be a function of altered metabolic states between tubules and/or functional demand that requires a constant turnover of mitochondria. Indeed, oxygen consumption is believed to be greater in PCTs versus DCTs [131](#febs14336-bib-0131){ref-type="ref"}. It could also be that PCT mitochondria are more vulnerable to mitochondrial stress than their DCT counterparts, although this is highly speculative and the actual comparative mitochondrial biology between these structures remains to be elaborated in greater mechanistic detail. Nonetheless, comparative mitochondrial differences between tubules have been described. For example, mitochondrial membrane potential is reported to be different between DCTs and PCTs [132](#febs14336-bib-0132){ref-type="ref"}. The same study reports higher ROS production in PCTs than DCTs. Taken together, these collective observations highlight the need for a deeper understanding of the interplay between mitochondrial metabolism and mitophagy within different cell subtypes *in vivo*.

![Mitophagy in the cortex of the adult kidney. Upper panels show a confocal micrograph (tile scan) of a section of adult kidney cortex from the *mito*‐QC reporter mouse under basal conditions. Note the distinct and polarised degree of mitophagy, as visualised by the ring‐like mCherry (red) signals, in a subset of kidney tubules (PCTs). Scale bar, 200 μm. Lower panels show a magnified *mito*‐QC PCT cell detailing the GFP and mCherry mitochondrial signals. Arrows highlight mCherry‐only signal co‐localising with LAMP1, a marker for lysosomes, confirming mitophagy. Scale bar, 5 μm. For details see McWilliams *et al*. [121](#febs14336-bib-0121){ref-type="ref"}.](FEBS-285-1185-g003){#febs14336-fig-0003}

The selective nature of autophagy *in vivo* is also highlighted when evaluating *mito*‐QC data in the context of pioneering studies by Mizushima on *in vivo* autophagy [133](#febs14336-bib-0133){ref-type="ref"}. Elegant work using a general autophagy reporter (GFP‐LC3) mouse model showed elevated LC3‐positive autophagosomes in adult kidney glomeruli, indicating elevated general autophagy in this renal structure. However, in *mito*‐QC animals, low levels of mitophagy were observed in adult glomeruli compared with tubules. Unexpectedly, during embryonic development, this distinct renal mitophagy is reversed, with elevated mitochondrial turnover occurring in glomeruli but not tubules [121](#febs14336-bib-0121){ref-type="ref"}. Therefore, not only are the physiological instances of autophagy highly context dependent but also demonstrate remarkable specificity, in this case for mitophagy.

Mitophagy modalities: intracellular and extracellular destruction {#febs14336-sec-0020}
-----------------------------------------------------------------

Autophagy has been classically studied as an intracellular, self‐catabolic quality control pathway. However, it is emerging that this assumption may not be entirely accurate. Davis *et al*. [134](#febs14336-bib-0134){ref-type="ref"} reported the trans‐cellular elimination of mitochondria *in vivo*. They observed that neuronal mitochondria targeted for elimination were expelled from axonal evulsions within the optic nerve head and degraded by neighbouring glial cells. It will be important to understand and further elaborate how 'axonal‐trans mitophagy' and other extracellular mitochondrial trafficking mechanisms contribute to mitochondrial homeostasis *in vivo*. These data challenge our assumptions of mitochondrial quality control pathways as being intrinsic to a particular cell and highlight the importance of studying mitochondrial homeostasis in the context of the neurogliovascular unit -- a fundamental entity of the nervous system *in vivo* [54](#febs14336-bib-0054){ref-type="ref"}.

The future {#febs14336-sec-0021}
==========

Taken together, these discoveries demonstrate that further research is required to understand the orchestration of metabolism and mitophagy and their contribution to tissue development and long‐term function. The molecular regulation of these processes remains enigmatic. It is, thus, accurate and appropriate to conclude that *in vivo* mitophagy remains a complex, context‐dependent process: the next frontier of mitophagy research.
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